A Tutorial on Time-Dependent Cohort State-Transition Models in R Using a Cost-Effectiveness Analysis Example

被引:5
作者
Alarid-Escudero, Fernando [1 ,2 ,3 ]
Krijkamp, Eline [4 ,5 ,6 ]
Enns, Eva A. [7 ]
Yang, Alan [8 ]
Hunink, M. G. Myriam [4 ,5 ,9 ]
Pechlivanoglou, Petros [8 ,10 ]
Jalal, Hawre [11 ]
机构
[1] Stanford Univ, Sch Med, Dept Hlth Policy, 615 Crothers Way,117 Encina Commons,MC 6019, Stanford, CA 94305 USA
[2] Stanford Univ, Stanford Hlth Policy, Freeman Spogli Inst Int Studies, 615 Crothers Way,117 Encina Commons,MC 6019, Stanford, CA 94305 USA
[3] Ctr Res & Teaching Econ CIDE, Div Publ Adm, Aguascalientes, Aguascalientes, Mexico
[4] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands
[5] Erasmus MC, Dept Radiol, Rotterdam, Netherlands
[6] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands
[7] Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, Minneapolis, MN USA
[8] Hosp Sick Children, Toronto, ON, Canada
[9] Harvard TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA USA
[10] Univ Toronto, Toronto, ON, Canada
[11] Univ Ottawa, Ottawa, ON, Canada
基金
美国国家卫生研究院;
关键词
cohort state-transition models; cost-effectiveness analysis; markov models; R software; time-dependent; tutorial; PROBABILITIES; STRATEGIES; DISEASE;
D O I
10.1177/0272989X221121747
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
In an introductory tutorial, we illustrated building cohort state-transition models (cSTMs) in R, where the state transition probabilities were constant over time. However, in practice, many cSTMs require transitions, rewards, or both to vary over time (time dependent). This tutorial illustrates adding 2 types of time dependence using a previously published cost-effectiveness analysis of multiple strategies as an example. The first is simulation-time dependence, which allows for the transition probabilities to vary as a function of time as measured since the start of the simulation (e.g., varying probability of death as the cohort ages). The second is state-residence time dependence, allowing for history by tracking the time spent in any particular health state using tunnel states. We use these time-dependent cSTMs to conduct cost-effectiveness and probabilistic sensitivity analyses. We also obtain various epidemiological outcomes of interest from the outputs generated from the cSTM, such as survival probability and disease prevalence, often used for model calibration and validation. We present the mathematical notation first, followed by the R code to execute the calculations. The full R code is provided in a public code repository for broader implementation.
引用
收藏
页码:21 / 41
页数:21
相关论文
共 36 条
  • [1] Expected value of sample information calculations in medical decision modeling
    Ades, AE
    Lu, G
    Claxton, K
    [J]. MEDICAL DECISION MAKING, 2004, 24 (02) : 207 - 227
  • [2] Alarid-Escudero F., 2018, Med Decis Making
  • [3] Alarid-Escudero F., 2021, DECISION ANAL MODELI
  • [4] A Need for Change! A Coding Framework for Improving Transparency in Decision Modeling
    Alarid-Escudero, Fernando
    Krijkamp, Eline M.
    Pechlivanoglou, Petros
    Jalal, Hawre
    Kao, Szu-Yu Zoe
    Yang, Alan
    Enns, Eva A.
    [J]. PHARMACOECONOMICS, 2019, 37 (11) : 1329 - 1339
  • [5] "Time Traveling Is Just Too Dangerous" but Some Methods Are Worth Revisiting: The Advantages of Expected Loss Curves Over Cost-Effectiveness Acceptability Curves and Frontier
    Alarid-Escudero, Fernando
    Enns, Eva A.
    Kuntz, Karen M.
    Michaud, Tzeyu L.
    Jalal, Hawre
    [J]. VALUE IN HEALTH, 2019, 22 (05) : 611 - 618
  • [6] Arias Elizabeth, 2017, Natl Vital Stat Rep, V66, P1
  • [7] Probabilistic analysis of cost-effectiveness models: Choosing between treatment strategies for gastroesophageal reflux disease
    Briggs, AH
    Goeree, R
    Blackhouse, G
    O'Brien, BJ
    [J]. MEDICAL DECISION MAKING, 2002, 22 (04) : 290 - 308
  • [8] Model Parameter Estimation and Uncertainty Analysis: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-6
    Briggs, Andrew H.
    Weinstein, Milton C.
    Fenwick, Elisabeth A. L.
    Karnon, Jonathan
    Sculpher, Mark J.
    Paltiel, A. David
    [J]. MEDICAL DECISION MAKING, 2012, 32 (05) : 722 - 732
  • [9] Survival Modeling for the Estimation of Transition Probabilities in Model-Based Economic Evaluations in the Absence of Individual Patient Data: A Tutorial
    Diaby, Vakaramoko
    Adunlin, Georges
    Montero, Alberto J.
    [J]. PHARMACOECONOMICS, 2014, 32 (02) : 101 - 108
  • [10] Cost-Effectiveness of Aspirin Adherence for Secondary Prevention of Cardiovascular Events
    Djatche L.M.
    Varga S.
    Lieberthal R.D.
    [J]. PharmacoEconomics - Open, 2018, 2 (4) : 371 - 380